Supporting data for “Investigation of the Immunogenicity and Antitumor Efficacy of Human PD1-based TWIST1 DNA Vaccine”

The experimental data covers the following main components:1. DNA Plasmids Construction - This section details the construction and development of the DNA plasmids used in the study. 2. DNA vaccines in vitro expression and binding characteristic - This examines the in vitro expression and binding properties of the DNA vaccine candidates. 3. Cellular Immune Response - This evaluates the cellular immune responses generated by the DNA vaccine formulations. 4. Humoral Immune Response - This assesses the humoral (antibody-mediated) immune responses elicited by the DNA vaccines. 5. Antitumor Efficacy - This section investigates the ability of the DNA vaccines to demonstrate antitumor efficacy in the Balb/c mouse models.